Treatment IND in United Arab Emirates
How the treatment ind pathway operates in United Arab Emirates.
About Treatment IND
US FDA treatment Investigational New Drug category.
How Treatment IND works in United Arab Emirates
The UAE recognises a formal Named Patient / compassionate-use pathway via MOHAP and the Department of Health Abu Dhabi (DoH). Physicians apply on behalf of individual patients for drugs not registered in-country.
Patients in United Arab Emirates seeking access under Treatment IND typically follow this flow: a licensed physician in United Arab Emirates issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in United Arab Emirates
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 1 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.